Healthcare SaaS Pivot: Drug Reference Apps Bet $1.61B Market on AI Premium Tiers
The global drug reference application market is witnessing a strategic shift as major platforms like Epocrates and UpToDate integrate LLM-powered clinical assistants, signaling an industry-wide transition from freemium dominance to premium subscription models. With the market valued at $1.61 billion in 2026, early adoption metrics—including 400,000 uses of NHS prescription tracking in just 10 weeks—suggest healthcare providers will pay for AI features that demonstrate measurable ROI.
ViaNews Editorial Team (Finance)•